Risk Factor Variability and Cardiovascular Outcome: JACC Review Topic of the Week

FH Messerli, L Hofstetter, SF Rimoldi, E Rexhaj… - Journal of the American …, 2019‏ - jacc.org
Until recently, intraindividual visit-to-visit variability of cardiovascular risk factors has been
dismissed as random fluctuation. This simplistic concept was challenged by demonstrating …

Apolipoprotein B, residual cardiovascular risk after acute coronary syndrome, and effects of alirocumab

E Hagström, PG Steg, M Szarek, DL Bhatt, VA Bittner… - Circulation, 2022‏ - ahajournals.org
Background: Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk.
Whether apoB levels and apoB lowering hold incremental predictive information on residual …

[HTML][HTML] Lipid variability and risk of cardiovascular diseases and all-cause mortality: a systematic review and meta-analysis of cohort studies

S Li, L Hou, S Zhu, Q Yi, W Liu, Y Zhao, F Wu, X Li… - Nutrients, 2022‏ - mdpi.com
No consensus has yet been reached on the associations of lipid variability (LV) with
cardiovascular diseases (CVDs) and all-cause mortality. We aimed to quantify the …

Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning

S Lee, J Zhou, WT Wong, T Liu, WKK Wu… - BMC endocrine …, 2021‏ - Springer
Introduction Recent studies have reported that HbA1c and lipid variability is useful for risk
stratification in diabetes mellitus. The present study evaluated the predictive value of the …

Triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, a simple but effective indicator in predicting type 2 diabetes mellitus in older adults

H Liu, J Liu, J Liu, S **n, Z Lyu, X Fu - Frontiers in Endocrinology, 2022‏ - frontiersin.org
Background A simple and readily available biomarker can provide an effective approach for
the surveillance of type 2 diabetes mellitus (T2DM) in the elderly. In this research, we aim to …

Intensive early and sustained lowering of non–high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry

J Schubert, M Leosdottir, B Lindahl… - European Heart …, 2024‏ - academic.oup.com
Abstract Background and Aims Non–HDL-C provides an estimate of lipid-associated risk
and is a secondary treatment target after myocardial infarction (MI). The aim was to study the …

Low lipid levels and high variability are associated with the risk of new‐onset atrial fibrillation

HJ Lee, SR Lee, EK Choi, KD Han… - Journal of the American …, 2019‏ - ahajournals.org
Background While high levels of lipids and lipid variability are established risk factors for
atherosclerotic cardiovascular disease, their roles in the development of atrial fibrillation …

Effect of blood lipid variability on mortality in patients with type 2 diabetes: a large single-center cohort study

MC Wang, CI Li, CS Liu, CH Lin, SY Yang, TC Li… - Cardiovascular …, 2021‏ - Springer
Background Dyslipidemia is a major cardiovascular risk factor and common in diabetes
patients. Most guidelines focus on optimal lipid levels, while variation of lipid profiles is far …

Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10‐year diabetes cohort study

EYF Wan, EYT Yu, WY Chin, JK Barrett… - Diabetes, Obesity …, 2020‏ - Wiley Online Library
Aim To examine the associations between variability in lipids and the risk of cardiovascular
disease (CVD) and mortality in patients with type 2 diabetes based on low‐density …

Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention

EY Lee, Y Yang, HS Kim, JH Cho, KH Yoon, WS Chung… - Atherosclerosis, 2018‏ - Elsevier
Background and aims Visit-to-visit variability in biological measures has been suggested as
an independent predictor of cardiovascular disease (CVD). Although low-density lipoprotein …